Abstract
The aim of this study was to determine whether interleukin-10 (IL-10) polymorphisms are associated with susceptibility to Behcet’s disease (BD). A meta-analysis was conducted, examining the associations between the IL-10 − 1082 G/A, − 819 C/T, and − 592 C/A polymorphisms and BD in various ethnic groups. Fourteen studies involving 5992 patients and 8966 controls were considered in the meta-analysis. Meta-analysis of the IL-10 − 1082 G/A polymorphism showed no association between BD and the − 1082 G allele (odds ratio (OR) = 0.951, 95% confidence interval (CI) = 0.790–1.146, p = 0.601). Meta-analysis of the IL-10 − 819 C/T polymorphism revealed a significant association between BD and the − 819 C allele (OR = 0.751, 95% CI = 0.684–0.825, p < 0.001) in all study subjects. Stratification by ethnicity indicated a significant association between the − 819 C allele and BD in Turkish (OR = 0.779, 95% CI = 0.709–0.856, p < 0.001) and Asian (OR = 0.676, 95% CI = 0.631–0.725, p < 0.001), but not in Middle Eastern populations. Meta-analysis of the − 592 C allele showed an association with BD in all study subjects (OR = 0.792, 95% CI = 0.662–0.948, p = 0.011) Stratification by ethnicity indicated a significant association between the − 592 C allele and BD in Asian populations (OR = 0.656, 95% CI = 0.512–0.841, p = 0.001). This meta-analysis showed that the IL-10 − 819 C/T and − 592 C/A polymorphisms are associated with BD susceptibility, especially in Asian population.
Similar content being viewed by others
References
Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med. 1999;341:1284–91.
Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet. 1990;335:1078–80.
Moore KW, de Waal MR, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.
Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol. 1992;148:1143–8.
Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens. 1997;49:635–9.
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.
Guzowski D, Chandrasekaran A, Gawel C, Palma J, Koenig J, Wang XP, et al. Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech. 2005;16:154–66.
Lopez P, Gutierrez C, Suarez A. IL-10 and TNFalpha genotypes in SLE. J Biomed Biotechnol. 2010;838390.
Vázquez-Villamar M, Palafox-Sánchez C, Hernández-Bello J, Muñoz-Valle J, Valle Y, Cruz A, et al. Frequency distribution of interleukin-10 haplotypes (-1082 A> G,-819 C> T, and-592 C> A) in a Mexican population. Genet Mol Res. 2016;15:1–11.
Monach PA, Merkel PA. Genetics of vasculitis. Curr Opin Rheumatol. 2010;22:157–63.
Afkari B, Babaloo Z, Dolati S, Khabazi A, Jadidi-Niaragh F, Talei M, et al. Molecular analysis of interleukin-10 gene polymorphisms in patients with Behcet’s disease. Immunol Lett. 2018;194:56–61.
Baris S, Akyurek O, Dursun A, Akyol M. The impact of the IL-1beta, IL-1Ra, IL-2, IL-6 and IL-10 gene polymorphisms on the development of Behcet’s disease and their association with the phenotype. Med Clin (Barc). 2016;146:379–83.
Yu H, Zheng M, Zhang L, Li H, Zhu Y, Cheng L, et al. Identification of susceptibility SNPs in IL10 and IL23R-IL12RB2 for Behcet’s disease in Han Chinese. J Allergy Clin Immunol. 2017;139:621–7.
Hu J, Hou S, Zhu X, Fang J, Zhou Y, Liu Y, et al. Interleukin-10 gene polymorphisms are associated with Behcet’s disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population. Mol Vis. 2015;21:589–603.
Carapito R, Shahram F, Michel S, le Gentil M, Radosavljevic M, Meguro A, et al. On the genetics of the silk route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Behcet’s disease in an Iranian population. Immunogenetics. 2015;67:289–93.
Al-Okaily F, Arfin M, Al-Rashidi S, Al-Balawi M, Al-Asmari A. Inflammation-related cytokine gene polymorphisms in Behçet’s disease. J Inflamm Res. 2015;8:173.
Talaat RM, Ashour ME, Bassyouni IH, Raouf AA. Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet’s disease. Immunobiology. 2014;219:573–82.
Wu Z, Zheng W, Xu J, Sun F, Chen H, Li P, et al. IL10 polymorphisms associated with Behcet’s disease in Chinese Han. Hum Immunol. 2014;75:271–6.
Montes-Cano MA, Conde-Jaldon M, Garcia-Lozano JR, et al. HLA and non-HLA genes in Behcet’s disease: a multicentric study in the Spanish population. Arthritis Res Ther. 2013;15:R145.
Shahram F, Nikoopour E, Rezaei N, Saeedfar K, Ziaei N, Davatchi F, et al. Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet’s disease. Clin Exp Rheumatol. 2011;29:S28–31.
Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Analyses of functional IL10 and TNF-alpha genotypes in Behcet’s syndrome. Mol Biol Rep. 2010;37:3637–41.
Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet. 2010;42:703–6.
Dilek K, Ozcimen AA, Saricaoglu H, Saba D, Yucel A, Yurtkuran M, et al. Cytokine gene polymorphisms in Behcet’s disease and their association with clinical and laboratory findings. Clin Exp Rheumatol. 2009;27:S73–8.
Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F, et al. IL-10 genotype analysis in patients with Behcet’s disease. Hum Immunol. 2007;68:122–7.
Lee YH. Association between the neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and rheumatoid arthritis and their correlations with the disease activity: a meta-analysis. J Rheum Dis. 2018;25:169–78.
Lee YH. Meta-analysis of genetic association studies. Ann Lab Med. 2015;35:283–7.
Lee YH, Song GG. Causal association between rheumatoid arthritis with the increased risk of type 2 diabetes: a Mendelian randomization analysis. J Rheum Dis. 2019;26:131–6.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315:1533–7.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999;42:1101–8.
Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics. 1997;46:120–8.
Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci. 1998;95:9465–70.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lee, Y.H., Song, G.G. Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to Behcet’s disease. Immunol Res 67, 424–431 (2019). https://doi.org/10.1007/s12026-019-09102-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-019-09102-x